RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026
RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026 CEO Shaun Bagai to Discuss RenovoRx's Commercial and Clinical Program Progress GlobeNewswire January 14, 2026 MOUNTAIN VIEW, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) — RenovoRx, Inc. (Nasdaq: RNXT) (“RenovoRx” or “the Company”), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath(R), a […]